RESUMO
We have recently shown that costs of surgical treatment for colorectal carcinoma differ greatly between various patient groups in the Netherlands. Those cost-differences could mostly be explained by the fact that high-risk patients have a greater risk of complications, which generate higher hospital costs. Hospitals with a high-risk population, for instant tertiary referral centres, spend more than hospitals that treat low-risk patients. Currently reimbursement however is not geared to risk differences. In this article we investigate this shortcoming of the current reimbursement system and discuss how a differential rewarding - in which reimbursement is aligned with the patient's risk profile - could serve as a tool to further quality improvement in healthcare. Current clinical registries may provide the necessary details of patient characteristics for risk profiling and may also contribute to the following goal: reimbursement based on the quality of delivered care.
Assuntos
Neoplasias Colorretais/economia , Neoplasias Colorretais/terapia , Atenção à Saúde/normas , Custos Hospitalares , Sistema de Registros , Gastos em Saúde , Humanos , Reembolso de Seguro de Saúde , Países Baixos , Avaliação de Processos e Resultados em Cuidados de Saúde , Melhoria de Qualidade , Centros de Atenção TerciáriaRESUMO
OBJECTIVE: The purpose of this study was to estimate the economic burden of postoperative complications after esophagectomy for cancer, in order to optimally allocate resources for quality improvement initiatives in the future. METHODS: A retrospective analysis of prospectively collected clinical and financial outcomes after esophageal cancer surgery in a tertiary referral center in the Netherlands was performed. Data was extracted from consecutive patients registered in the Dutch Upper GI Cancer Audit between 2011 and 2014 (n = 201). Costs were measured up to 90-days after hospital discharge and based on Time-Driven Activity-Based Costing. The additional costs were estimated using multiple linear regression models. RESULTS: The average total cost for one patient after esophagectomy was 37,581 (±31,372). The estimated costs of an esophagectomy without complications were 23,476 (±6496). Mean costs after minor (47%) and severe complications (29%) were 31,529 (±23,359) and 59,167 (±42,615) (p < 0.001), respectively. The 5% most expensive patients were responsible for 20.3% of the total hospital costs assessed in this study. Patient characteristics associated with additional costs in multivariable analysis included, age >70 (+2,922, p = 0.036), female gender (+4,357, p = 0.005), COPD (+5,415, p = 0.002), and a history of thromboembolic events (+6,213, p = 0.028). Complications associated with a significant increase in costs in multivariable analysis included anastomotic leakage (+4,123, p = 0.008), cardiac complications (+5,711, p = 0.003), chyle leakage (+6,188, p < 0.001) and postoperative bleeding (+31,567, p < 0.001). CONCLUSIONS: Complications and severity of complications after esophageal surgery are associated with a substantial increase in costs. Although not all postoperative complications can be prevented, implementation of preventive measures to reduce complications could result in a considerable cost reduction and quality improvement.
Assuntos
Neoplasias Esofágicas/cirurgia , Esofagectomia , Custos Hospitalares , Complicações Pós-Operatórias/economia , Fatores Etários , Idoso , Fístula Anastomótica/economia , Comorbidade , Bases de Dados Factuais , Neoplasias Esofágicas/epidemiologia , Feminino , Cardiopatias/economia , Humanos , Modelos Lineares , Masculino , Análise Multivariada , Países Baixos/epidemiologia , Hemorragia Pós-Operatória/economia , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Melhoria de Qualidade , Estudos Retrospectivos , Fatores Sexuais , Tromboembolia/epidemiologiaRESUMO
BACKGROUND: Healthcare providers worldwide are struggling with rising costs while hospitals budgets are under stress. Colorectal cancer surgery is commonly performed, however it is associated with a disproportionate share of adverse events in general surgery. Since adverse events are associated with extra hospital costs it seems important to explicitly discuss the costs of complications and the risk factors for high-costs after colorectal surgery. METHODS: Retrospective analysis of clinical and financial outcomes after colorectal cancer surgery in 29 Dutch hospitals (6768 patients). Detailed clinical data was derived from the 2011-2012 population-based Dutch Surgical Colorectal Audit database. Costs were measured uniform in all participating hospitals and based on Time-Driven Activity-Based Costing. FINDINGS: Of total hospital costs in this study, 31% was spent on complications and the top 5% most expensive patients were accountable for 23% of hospitals budgets. Minor and severe complications were respectively associated with a 26% and 196% increase in costs as compared to patients without complications. Independent from other risk factors, ASA IV, double tumor, ASA III, short course preoperative radiotherapy and TNM-4 stadium disease were the top-5 attributors to high costs. CONCLUSIONS: This article shows that complications after colorectal cancer surgery are associated with a substantial increase in costs. Although not all surgical complications can be prevented, reducing complications will result in considerable cost savings. By providing a business case we show that investments made to develop targeted quality improvement programs will pay off eventually. Results based on this study should encourage healthcare providers to endorse quality improvement efforts.